Literature DB >> 28674117

Genetic Counselor Recommendations for Cancer Predisposition Evaluation and Surveillance in the Pediatric Oncology Patient.

Harriet Druker1,2, Kristin Zelley3, Rose B McGee4, Sarah R Scollon5, Wendy K Kohlmann6, Katherine A Schneider7, Kami Wolfe Schneider8.   

Abstract

As the understanding of the genetic etiology of childhood cancers increases, the need for the involvement of experts familiar with the provision of genetic counseling for this population is paramount. In October 2016, the American Association for Cancer Research organized the AACR Childhood Cancer Predisposition Workshop in which international experts in pediatric cancer predisposition met to establish surveillance guidelines for children with cancer predisposition. Identifying for whom, when, why, and how these cancer predisposition surveillance guidelines should be implemented is essential. Genetic counselors invited to this workshop provide a genetic counseling framework for oncology professionals in this article. Points of entry and recommendations regarding the provision and timing of the initial and subsequent genetic counseling sessions are addressed. The genetic counseling and testing processes are reviewed, and the psychologic impact related to surveillance is explored. Pediatric cancer genetics will continue to grow and evolve as a field, and genetic counseling services will be vital to ensure appropriate identification and management of at-risk children moving forward. Clin Cancer Res; 23(13); e91-e97. ©2017 AACRSee all articles in the online-only CCR Pediatric Oncology Series. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2017        PMID: 28674117     DOI: 10.1158/1078-0432.CCR-17-0834

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  21 in total

Review 1.  Ethical conundrums in pediatric genomics.

Authors:  Seth J Rotz; Eric Kodish
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 2.  Using genomics to define pediatric blood cancers and inform practice.

Authors:  Rachel E Rau; Mignon L Loh
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 3.  Genetic defects in hematopoietic transcription factors and predisposition to acute lymphoblastic leukemia.

Authors:  Yoshihiro Gocho; Jun J Yang
Journal:  Blood       Date:  2019-07-16       Impact factor: 22.113

4.  Utilization of clinical genetic counseling among childhood and young adult cancer survivors in a registry trial.

Authors:  Nassim Anderson; Arash Delavar; Danielle Novetsky Friedman; Vijai Joseph; Nidha Mubdi; Kevin C Oeffinger; Charles A Sklar; Kenneth Offit; Matthew Matasar; Nirupa Raghunathan; Zoltan Antal; David Straus; Michael Walsh; Alicia Latham; Emily S Tonorezos
Journal:  J Community Genet       Date:  2020-07-16

5.  Germ Cell Mosaicism: A Rare Cause of Li-Fraumeni Recurrence Among Siblings.

Authors:  Lauren N Donovan; Wendy Kohlmann; Angela K Snow; Deborah W Neklason; Joshua D Schiffman; Luke Maese
Journal:  JCO Precis Oncol       Date:  2020-06-16

Review 6.  Germline Genetics and Childhood Cancer: Emerging Cancer Predisposition Syndromes and Psychosocial Impacts.

Authors:  Sarah G Mitchell; Bojana Pencheva; Christopher C Porter
Journal:  Curr Oncol Rep       Date:  2019-08-15       Impact factor: 5.075

7.  ETV6-related thrombocytopenia and leukemia predisposition.

Authors:  Jorge Di Paola; Christopher C Porter
Journal:  Blood       Date:  2019-06-27       Impact factor: 22.113

Review 8.  Imaging of cancer predisposition syndromes.

Authors:  Mary-Louise C Greer
Journal:  Pediatr Radiol       Date:  2018-08-04

9.  An ethical framework for genetic counseling in the genomic era.

Authors:  Leila Jamal; Will Schupmann; Benjamin E Berkman
Journal:  J Genet Couns       Date:  2019-12-19       Impact factor: 2.717

10.  Germline cancer predisposition variants and pediatric glioma: a population-based study in California.

Authors:  Ivo S Muskens; Adam J de Smith; Chenan Zhang; Helen M Hansen; Libby Morimoto; Catherine Metayer; Xiaomei Ma; Kyle M Walsh; Joseph L Wiemels
Journal:  Neuro Oncol       Date:  2020-06-09       Impact factor: 13.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.